NDC00075-0700-00: INDAPAMIDE TABLETS.
The INDAPAMIDE TABLETS is a the manufacturer industrial component. Key specifications include special_features: THERAPEUTIC EQUIVALENT TO LOZOL BY RHONE-POULENC RORER, primary_container_type: BOTTLE, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 100.000 TABLETS, active_medicament_medicinal_strength: 1.250 MILLIGRAMS INDAPAMIDE ACTIVE INGREDIENT, part_name_assigned_by_controlling_agency: INDAPAMIDE TABLETS USP 1.25MG 100S BT. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-377-1462, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| special_features | THERAPEUTIC EQUIVALENT TO LOZOL BY RHONE-POULENC RORER |
| primary_container_type | BOTTLE |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| primary_container_content_quantity | 100.000 TABLETS |
| active_medicament_medicinal_strength | 1.250 MILLIGRAMS INDAPAMIDE ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | INDAPAMIDE TABLETS USP 1.25MG 100S BT |
| NSN | 6505-01-377-1462 |
| PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BOTTLE |
| SPECIAL FEATURES | THERAPEUTIC EQUIVALENT TO LOZOL BY RHONE-POULENC RORER |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | INDAPAMIDE TABLETS USP 1.25MG 100S BT |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 1.250 MILLIGRAMS INDAPAMIDE ACTIVE INGREDIENT |